跳至主要内容
临床试验/NCT02100592
NCT02100592已完成1 期

Early Verticalization in neuroICU With ERIGO: a Safety and Feasibility Study

Ospedale Generale Di Zona Moriggia-Pelascini0 个研究点目标入组 8 人开始时间: 2012年10月1日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
8
主要终点
Adverse events during verticalization

研究概览

简要总结

Severe brain injuries induce alteration of state of consciousness. These functional limitations can be significantly alleviated by treatment neurorehabilitation, particularly if this is established early. It has been shown that treatment of vertical integration in patients in a vegetative state or minimally conscious state can improve the level of supervision and positive influence on rehabilitation. Therefore, there are sufficient indications that anticipate the treatment of vertical integration, since the phase of hospitalization in ICUs, may improve the functional outcome of the patient.

详细描述

Early verticalization and stepping with the equipment Hocoma Erigo, during monitoring of vital parameters. The device Erigo is already CE marked and, for the purposes of the study, will be used in accordance with the intended use of the same mark (after-market clinical investigation).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient / a severe acquired brain injury occurred 3 to 30 days prior to enrollment
  • Age between 18 and 75 years
  • Glasgow Coma Scale ≤ 8 at entrance in ICUs
  • Adequate respiratory exchange with PaO2/FiO2 ≥ 250
  • Absence of sedation increased

排除标准

  • Major chest trauma with multiple rib fractures and / or pneumothorax
  • Presence of fractures, vascular lesions, skin lesions with loss of substance in the abdomen, pelvis or lower limb
  • Cardiovascular instability despite support with amines
  • Intracranial pressure (ICP)> 25 mm / Hg
  • Cerebral Perfusion Pressure (PPC) <60 mm / Hg
  • Severe kidney failure requiring replacement therapy
  • Decompensated liver disease
  • Hematocrit value of ≤ 30%
  • Body weight> 135 kg or height> 210 cm
  • Deep vein thrombosis

结局指标

主要结局

Adverse events during verticalization

时间窗: 21 days: from T1 (first session) to T15 (last session)

It is a composite outcome, assessing the occurence of at least one of the following conditions (component outcomes): Heart rate \<40 bpm or\> 150 bpm; Mean arterial pressure \<70 mmHg; Arterial oxygen saturation \<90%; Onset of ECG anomalies; Traumatic dislodgement of a device;

次要结局

  • Changes of hemodynamic parameters(21 days: from T1 (first session) to T15 (last session))

研究者

发起方
Ospedale Generale Di Zona Moriggia-Pelascini
申办方类型
Other
责任方
Sponsor

相似试验